Breaking News, Financial News

Financial Report: AMRI 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 3Q Revenues: $61.4 million (+29%) 3Q Earnings: $7.0 million (+250%) YTD Revenues: $172.9 million (+19%) YTD Earnings: $17.4 million (+78%) Comments: Total contract revenue for the quarter was $54.1 million (+30%). Discovery Services revenue was $16.4 million (+57%). Development/Small Scale Manufacturing revenue was $14.5 million (+11%). Large Scale Manufacturing revenue was $23.2 million (+29%). Allegra royalties dropped 5% to $5.7 million. Milestone revenue from the company...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters